Huang Jennifer H, Sunstrom Rachel, Munar Myrna Y, Cherala Ganesh, Legg Arthur, Olyeai Ali J, Langley Stephen M
Division of Pediatric Cardiology, Doernbecher Children's Hospital, Oregon Health Science University, Portland, Ore.
Division of Pediatric Cardiac Surgery, Oregon Health Science University, Doernbecher Children's Hospital, Portland, Ore.
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1591-6. doi: 10.1016/j.jtcvs.2013.12.043. Epub 2014 Jan 15.
Perioperative antibiotics have decreased-but not eradicated-postoperative infections. In patients undergoing cardiac surgery with cardiopulmonary bypass, the dilutional effect of the priming and any additional volume given during the procedure may lead to subtherapeutic antibiotic levels. Our aim was to determine if children undergoing cardiac surgery with cardiopulmonary bypass receive perioperative antibiotics at subtherapeutic levels.
Using published pharmacokinetic data on cefuroxime, we developed a computer simulation model to generate a nomogram predicting patients at risk for subtherapeutic cefuroxime levels based on time from initial dosing and additional volume given.
A computer-generated 1-compartment pharmacokinetic model was created to predict cefuroxime plasma levels over time for patients of all weights and additional volumes given for both a 25- and 50-mg/kg intravenous dose. For example, following a 25-mg/kg dose, a patient receiving an additional volume of 275 mL/kg is predicted to be subtherapeutic (<16 mg/L=4×minimum inhibitory concentration) at 4 hours. Our nomogram predicts all patients will be subtherapeutic at 8 hours, consistent with general pediatrics dosing schemes. Following a 50-mg/kg dose, levels are predicted to be subtherapeutic after an additional volume of 315 mL/kg at 5.5 hours.
Our model predicts which patients undergoing cardiac surgery with cardiopulmonary will have subtherapeutic cefuroxime levels. This nomogram enables providers to determine when to administer additional antibiotics in patients receiving large additional volumes during cardiac surgeries. This rational approach to perioperative antibiotic dosing may result in a reduction in postoperative infection in this vulnerable patient population.
围手术期使用抗生素已减少了术后感染,但尚未根除。在接受体外循环心脏手术的患者中,预充液的稀释作用以及手术过程中给予的任何额外容量可能导致抗生素水平低于治疗剂量。我们的目的是确定接受体外循环心脏手术的儿童围手术期使用的抗生素是否处于低于治疗剂量的水平。
利用已发表的头孢呋辛药代动力学数据,我们开发了一个计算机模拟模型,以生成一张列线图,根据首次给药后的时间和给予的额外容量预测头孢呋辛水平低于治疗剂量的风险患者。
创建了一个计算机生成的单室药代动力学模型,以预测所有体重患者以及给予25mg/kg和50mg/kg静脉剂量时不同额外容量下头孢呋辛随时间的血浆水平。例如,给予25mg/kg剂量后,预计接受额外容量275mL/kg的患者在4小时时低于治疗剂量(<16mg/L = 4×最低抑菌浓度)。我们的列线图预测所有患者在8小时时均低于治疗剂量,这与一般儿科给药方案一致。给予50mg/kg剂量后,预计在5.5小时给予额外容量315mL/kg后水平低于治疗剂量。
我们的模型预测哪些接受体外循环心脏手术的患者头孢呋辛水平会低于治疗剂量。这张列线图使医疗人员能够确定在心脏手术期间接受大量额外容量的患者何时给予额外抗生素。这种围手术期抗生素给药的合理方法可能会降低这一脆弱患者群体的术后感染率。